Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 3J396119JY

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Tyrosine-protein kinase JAK3 inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Graft vs Host Disease 2 D006086 ClinicalTrials
Dry Eye Syndromes 2 D015352 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL3545382
FDA SRS 3J396119JY
PubChem 23648971